Fc-fusion technology and recombinant FVIII and FIX in the management of the hemophilias

References

• Mannucci PM Tuddenham EG The hemophilias – from royal genes to gene therapy N Engl J Med 2001 344 23 1773 1779 11396445
   PubMed Web of Science ®Google Scholar
• Manco-Johnson MJ Abshire TC Shapiro AD Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia N Engl J Med 2007 357 6 535 544 17687129
   PubMed Web of Science ®Google Scholar
• Gringeri A Lundin B von Mackensen S Mantovani L Mannucci PM ESPRIT Study Group A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study) J Thromb Haemost 2011 9 4 700 710 21255253
   PubMed Web of Science ®Google Scholar
• Collins PW Blanchette VS Fischer K rAHF-PFM Study Group Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A J Thromb Haemost 2009 7 3 413 420 19143924
   PubMed Web of Science ®Google Scholar
• Collins PW Björkman S Fischer K Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens J Thromb Haemost 2010 8 2 269 275 19943875
   PubMed Web of Science ®Google Scholar
• Valentino LA Kawji M Grygotis M Venous access in the management of hemophilia Blood Rev 2011 25 1 11 15 21030121
   PubMed Web of Science ®Google Scholar
• Powell JS Josephson NC Quon D Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients Blood 2012 119 13 3031 3037 22223821
   PubMed Web of Science ®Google Scholar
• Shapiro AD Ragni MV Valentino LA Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients Blood 2012 119 3 666 672 22110246
   PubMed Web of Science ®Google Scholar
• Mahlangu J Powell JS Ragni MV Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A Blood 2014 123 317 325 24227821
   PubMed Web of Science ®Google Scholar
• Powell JS Pasi KJ Ragni MV Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B N Engl J Med 2013 369 2313 2323 24304002
   PubMed Web of Science ®Google Scholar
• Fisher CJ Agosti JM Opal SM Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group N Engl J Med 1996 334 26 1697 1702 8637514
   PubMed Web of Science ®Google Scholar
• Ellis CN Krueger GG Alefacept Clinical Study Group Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes N Engl J Med 2001 345 4 248 255 11474662
   PubMed Web of Science ®Google Scholar
• Genovese MC Becker JC Schiff M Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition N Engl J Med 2005 353 11 1114 1123 16162882
   PubMed Web of Science ®Google Scholar
• Israel EJ Taylor S Wu Z Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells Immunology 1997 92 1 69 74 9370926
   PubMed Web of Science ®Google Scholar
• Spiekermann GM Finn PW Ward ES Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung J Exp Med 2002 196 3 303 310 12163559
   PubMed Web of Science ®Google Scholar
• Haymann JP Levraud JP Bouet S Characterization and localization of the neonatal Fc receptor in adult human kidney J Am Soc Nephrol 2000 11 4 632 639 10752522
   PubMed Web of Science ®Google Scholar
• Antohe F Rădulescu L Gafencu A Gheţie V Simionescu M Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells Hum Immunol 2001 62 2 93 105 11182218
   PubMed Web of Science ®Google Scholar
• Ward ES Zhou J Ghetie V Ober RJ Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans Int Immunol 2003 15 2 187 195 12578848
   PubMed Web of Science ®Google Scholar
• Ober RJ Martinez C Vaccaro C Zhou J Ward ES Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn J Immunol 2004 172 4 2021 2029 14764666
   PubMed Web of Science ®Google Scholar
• Lencer WI Blumberg RS A passionate kiss, then run: exocytosis and recycling of IgG by FcRn Trends Cell Biol 2005 15 1 5 9 15653072
   PubMed Web of Science ®Google Scholar
• McGarry T Hough R Rogers S Rechsteiner M Intracellular distribution and degradation of immunoglobulin G and immunoglobulin G fragments injected into HeLa cells J Cell Biol 1983 96 2 338 346 6403551
   PubMed Web of Science ®Google Scholar
• Desai MA Mutlu M Vadgama P A study of macromolecular diffusion through native porcine mucus Experientia 1992 48 1 22 26 1737572
   PubMedGoogle Scholar
• Bitonti AJ Dumont JA Low SC Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway Proc Natl Acad Sci U S A 2004 101 26 9763 9768 15210944
   PubMed Web of Science ®Google Scholar
• Peters RT Low SC Kamphaus GD Prolonged activity of factor IX as a monomeric Fc fusion protein Blood 2010 115 10 2057 2064 20056791
   PubMed Web of Science ®Google Scholar
• Goldenberg MM Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis Clin Ther 1999 21 1 75 87 discussion 1–2 10090426
   PubMed Web of Science ®Google Scholar
• Dumont JA Liu T Low SC Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs Blood 2012 119 13 3024 3030 22246033
   PubMed Web of Science ®Google Scholar
• Peters RT Toby G Lu Q Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein J Thromb Haemost 2013 11 1 132 141 23205847
   PubMed Web of Science ®Google Scholar
• Swiech K Picanço-Castro V Covas DT Human cells: new platform for recombinant therapeutic protein production Protein Expr Purif 2012 84 1 147 153 22580292
   PubMed Web of Science ®Google Scholar
• Ghaderi D Zhang M Hurtado-Ziola N Varki A Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation Biotechnol Genet Eng Rev 2012 28 147 175 22616486
   PubMed Web of Science ®Google Scholar
• White GC2nd Beebe A Nielsen B Recombinant factor IX Thromb Haemost 1997 78 1 261 265 9198163
   PubMed Web of Science ®Google Scholar
• Roth DA Kessler CM Pasi KJ Rup B Courter SG Tubridy KL Recombinant Factor IX Study Group Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates Blood 2001 98 13 3600 3606 11739163
   PubMed Web of Science ®Google Scholar
• Biogen Idec Study of Recombinant Coagulation Factor VIII Fc Fusion Protein, BIIB 031, in Pediatric PTP Subjects With Hemophilia A Updated December 12, 2013. Available from: http://clinicaltrials.gov/show/NCT01458106. NLM identifier: NCT01458106 Accessed February 17, 2014
   Google Scholar
• ClinicalTrials.gov Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor VIII Fusion Protein (rFVIIIFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia A Last updated September 12, 2013. Available from: http://clinicaltrials.gov/show/NCT01454739
   Google Scholar
• ClinicalTrials.gov Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB 029, in Pediatric PTP Subjects With Hemophilia B Updated September 12, 2013. Available from: http://clinicaltrials.gov/show/NCT01440946
   Google Scholar
• ClinicalTrials.gov Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B (B-YOND) Last updated September 12, 2013. Available from: http://clinicaltrials.gov/show/NCT01425723
   Google Scholar
• Santagostino E Negrier C Klamroth R Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients Blood 2012 120 12 2405 2411 22859609
   PubMed Web of Science ®Google Scholar